Opko
Health Inc. (NYSE: OPK) will acquire Bio-Reference Laboratories Inc. (Nasdaq:
BRLI) in an all stock deal valued at approximately $1.5 billion. Shares of Opko Health plunged $2.87 to close at $16.25 while Bio-Reference Laboratories jumped $6.64 to close at $39.60.
Opko Health to buy Bio-Reference Laboratories
June 04, 2015 at 17:10 PM EDT
